Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)

NCT01895764 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Adalimumab
DRUG: Methotrexate

Sponsor

University Hospital, Tours